Hypothalamic mTOR Signaling Regulates Food Intake

Daniela Cota(Human Genome Sciences (United States)), Karine Proulx(Human Genome Sciences (United States)), Kathi A. Blake Smith(Human Genome Sciences (United States)), Sara C. Kozma(Human Genome Sciences (United States)), George Thomas(Human Genome Sciences (United States)), Stephen C. Woods(Human Genome Sciences (United States)), Randy J. Seeley(Human Genome Sciences (United States))
Science
May 11, 2006
Cited by 1,264

Abstract

The mammalian Target of Rapamycin (mTOR) protein is a serine-threonine kinase that regulates cell-cycle progression and growth by sensing changes in energy status. We demonstrated that mTOR signaling plays a role in the brain mechanisms that respond to nutrient availability, regulating energy balance. In the rat, mTOR signaling is controlled by energy status in specific regions of the hypothalamus and colocalizes with neuropeptide Y and proopiomelanocortin neurons in the arcuate nucleus. Central administration of leucine increases hypothalamic mTOR signaling and decreases food intake and body weight. The hormone leptin increases hypothalamic mTOR activity, and the inhibition of mTOR signaling blunts leptin's anorectic effect. Thus, mTOR is a cellular fuel sensor whose hypothalamic activity is directly tied to the regulation of energy intake.


Related Papers

No related papers found

Powered by citation graph analysis